Scarica l'app Stockscreener
0.34
8.80%
0.0275
Dopo l'orario di chiusura:
.29
-0.05
-14.71%
Precedente Chiudi:
$0.3125
Aprire:
$0.31
Volume 24 ore:
2.05M
Relative Volume:
1.98
Capitalizzazione di mercato:
$1.79M
Reddito:
-
Utile/perdita netta:
$-11.53M
Rapporto P/E:
-0.0705
EPS:
-4.82
Flusso di cassa netto:
$-11.12M
1 W Prestazione:
-12.60%
1M Prestazione:
-30.65%
6M Prestazione:
-71.43%
1 anno Prestazione:
-85.34%
Intervallo 1D:
$0.2815
$0.3647
Intervallo di 1 settimana:
$0.24
$0.4878
Portata 52W:
$0.24
$3.305
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Nome
Processa Pharmaceuticals Inc
Settore
Industria
Telefono
443-776-3133
Indirizzo
7380 COCA COLA DRIVE, HANOVER
Confronta PCSA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
0.34 | 1.79M | 0 | -11.53M | -11.12M | -4.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-25 | Iniziato | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Borsa (PCSA) Ultime notizie
Processa Pharmaceuticals stock hits 52-week low at $0.36 - Investing.com
Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Friday - Defense World
Processa Pharmaceuticals stock hits 52-week low at $0.4 By Investing.com - Investing.com Australia
Processa Pharmaceuticals stock hits 52-week low at $0.4 - Investing.com
Processa Pharmaceuticals, Inc. SEC 10-K Report - TradingView
Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Thursday - Defense World
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference - The Manila Times
Cancer Therapy Innovator Processa Pharmaceuticals Opens Door to Investors at Elite MedInvest Conference - StockTitan
Processa Pharmaceuticals stock hits 52-week low at $0.43 By Investing.com - Investing.com Australia
Processa Pharmaceuticals stock hits 52-week low at $0.43 - Investing.com India
Ulcerated Necrobiosis Lipoidica Market to Expand Significantly by 2034, States DelveInsight Reports | Processa Pharmaceuticals - Barchart
Processa Pharmaceuticals stock hits 52-week low at $0.46 - Investing.com
Processa Pharma Stock Price, Quotes and Forecasts - Benzinga
The Insider Secrets to Processa Pharmaceuticals: A Dark Horse in the Race - Elblog.pl
Hidden Gems: Why Insiders Are Banking on Processa Pharmaceuticals - Bit Perfect Solutions
Processa Pharmaceuticals, Inc. (PCSA): Among the Cheapest Stocks Insiders Are Buying Recently - Insider Monkey
10 Cheapest Stocks Insiders Are Buying Recently - Insider Monkey
Processa Pharmaceuticals faces Nasdaq delisting risk over share price By Investing.com - Investing.com Nigeria
Processa Pharmaceuticals (NASDAQ:PCSA) Publishes Investor Presentation - Defense World
Processa Pharmaceuticals faces Nasdaq delisting risk over share price - Investing.com
Processa Pharmaceuticals IncOn Feb 4, Received Nasdaq Notice For Bid Price Non-Compliance - Marketscreener.com
Processa Pharmaceuticals Inc (PCSA) Shares Soar Above 1-Year High - The News Heater
Processa Pharmaceuticals to Present at 2025 BIO CEO & Investor Conference - Nasdaq
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference - GlobeNewswire
Processa Pharma's Cancer Pipeline Takes Center Stage at Elite BIO Investor Conference - StockTitan
Gastroparesis Market Expected to rise, 2034 | Vanda - openPR
Financial Analysis: Processa Pharmaceuticals Inc (PCSA)’s Ratios Unveil Key Insights - The Dwinnex
Processa Pharmaceuticals CEO George Ng buys shares worth $69,542 - MSN
Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewswire
Processa Pharmaceuticals Raises $5M in Public Offering - TipRanks
Processa CEO Doubles Down: Purchases Shares at 30% Premium in $5M Strategic Raise - StockTitan
Processa Pharmaceuticals director David Young buys $99,288 in stock - Investing.com India
Processa Pharmaceuticals' chief business officer buys $34,691 in stock - MSN
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Processa Pharmaceuticals' chief business officer buys $34,691 in stock By Investing.com - Investing.com South Africa
Processa Pharmaceuticals director David Young buys $99,288 in stock By Investing.com - Investing.com South Africa
Processa Pharmaceuticals CEO George Ng buys shares worth $69,542 By Investing.com - Investing.com UK
Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewswire
Ulcerated Necrobiosis Lipoidica Market to Reach New Heights - openPR
Processa Pharmaceuticals stock hits 52-week low at $0.65 By Investing.com - Investing.com Canada
Processa Pharmaceuticals stock hits 52-week low at $0.65 - MSN
Processa CEO and Board Members Double Down: Major Insider Buying in Latest $5M Deal - StockTitan
Processa Pharmaceuticals Inc Azioni (PCSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Processa Pharmaceuticals Inc Azioni (PCSA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Ng George K | Chief Executive Officer |
Jan 27 '25 |
Buy |
0.80 |
87,200 |
69,542 |
87,200 |
| Young David | Pres. Research & Development |
Jan 27 '25 |
Buy |
0.80 |
124,500 |
99,289 |
205,405 |
| Lin Patrick | Chief Business - Strategy Off |
Jan 27 '25 |
Buy |
0.80 |
43,500 |
34,691 |
43,500 |
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):